Back to Agenda
S16 : Hints for Utilization of Real World Data in Drug Development -Maximization of RWD Utilization Value Corresponding to the Issue to be Solved-
Session Chair(s)
Yoshifumi Ukyo
Associate Director, Statistics & Decision Sciences
Janssen Pharmaceutical K.K., Japan
Solve the issue correctly with RWD!
Speaker(s)
Experience and Challenges of RWE Generation for Regulatory Purposes as a Database Provider
Masakatsu Hattori
Real World Data Co., Ltd., Japan
Director, Head of RWD Division
Consideration of Using RWD in Drug Evaluation
Sachiko Tanaka
Kyoto University, Japan
Department of Digital Health and Epidemiology/Professor
Chieko Ishiguro, PhD, MPH
National Center for Global Health and Medicine, Japan
Section Chief of Clinical Epidemiology, Department of Data Science
Have an account?